help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunone, G.
Right arrow Articles by Bongarzone, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunone, G.
Right arrow Articles by Bongarzone, I.
(American Journal of Pathology. 1999;155:1967-1976.)
© 1999 American Society for Investigative Pathology

Regular Articles

Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features

Giuseppe Bunone*, Paolo Vigneri*, Luigi Mariani{dagger}, Simona Butó{ddagger}, Paola Collini{ddagger}, Silvana Pilotti{ddagger}, Marco A. Pierotti* and Italia Bongarzone*

From the Divisions of Experimental Oncology,*
Medical Statistics and Biometry,{dagger}
and Pathology and Cytology,{ddagger}
Istituto Nazionale Tumori, Milan, Italy

Experimental evidence has shown, both in vitro and in animal models, that neoplastic growth and subsequent metastasis formation depend on the tumor’s ability to induce an angiogenic switch. This requires a change in the balance of angiogenic stimulators and inhibitors. To assess the potential role of angiogenesis factors in human thyroid tumor growth and spread, we analyzed their expression by semiquantitative RT-PCR and immunohistochemistry in normal thyroid tissues, benign lesions, and different thyroid carcinomas. Compared to normal tissues, in thyroid neoplasias we observed a consistent increase in vascular endothelial growth factor (VEGF), VEGF-C, and angiopoietin-2 and in their tyrosine kinase receptors KDR, Flt-4, and Tek. In particular, we report the overexpression of angiopoietin-2 and VEGF in thyroid tumor progression from a prevascular to a vascular phase. In fact, we found a strong association between tumor size and high levels of VEGF and angiopoietin-2. Furthermore, our results show an increased expression of VEGF-C in lymph node invasive thyroid tumors and, on the other hand, a decrease of thrombospondin-1, an angioinhibitory factor, in thyroid malignancies capable of hematic spread. These results suggest that, in human thyroid tumors, angiogenesis factors seem involved in neoplastic growth and aggressiveness. Moreover, our findings are in keeping with a recent hypothesis that in the presence of VEGF, angiopoietin-2 may collaborate at the front of invading vascular sprouts, serving as an initial angiogenic signal that accompanies tumor growth.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
M. Joao Bugalho, D. Madureira, C. Espadinha, A. Paula Font, and L. G Sobrinho
Serum vascular endothelial growth factor levels in patients with medullary thyroid carcinoma
Eur. J. Endocrinol., August 1, 2008; 159(2): 167 - 169.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. I. Sherman, L. J. Wirth, J.-P. Droz, M. Hofmann, L. Bastholt, R. G. Martins, L. Licitra, M. J. Eschenberg, Y.-N. Sun, T. Juan, et al.
Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
N. Engl. J. Med., July 3, 2008; 359(1): 31 - 42.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-P. Wu, M.-J. Young, C.-C. Tzeng, C.-R. Tzeng, K.-F. Huang, L.-W. Wu, and C.-Y. Chou
A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer
Carcinogenesis, June 1, 2008; 29(6): 1115 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
P.-J. Hsiao, M.-Y. Lu, F.-Y. Chiang, S.-J. Shin, Y.-D. Tai, and S.-H. H. Juo
Vascular endothelial growth factor gene polymorphisms in thyroid cancer
J. Endocrinol., November 1, 2007; 195(2): 265 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Klubo-Gwiezdzinska, R. Junik, E. Kopczynska, O. Juraniec, and H. Kardymowicz
The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter
Eur. J. Endocrinol., October 1, 2007; 157(4): 521 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Ayers, J. Fargnoli, A. Lewin, Q. Wu, and J. S. Platero
Discovery and Validation of Biomarkers that Respond to Treatment with Brivanib Alaninate, a Small-Molecule VEGFR-2/FGFR-1 Antagonist
Cancer Res., July 15, 2007; 67(14): 6899 - 6906.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Nahari, R. Satchi-Fainaro, M. Chen, I. Mitchell, L. B. Task, Z. Liu, J. Kihneman, A. B. Carroll, L. S. Terada, and F. E. Nwariaku
Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer
Mol. Cancer Ther., April 1, 2007; 6(4): 1329 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Kim, J. A. Franklyn, K. Boelaert, M. C. Eggo, J. C. Watkinson, and C. J. McCabe
Pituitary Tumor Transforming Gene (PTTG) Stimulates Thyroid Cell Proliferation via a Vascular Endothelial Growth Factor/Kinase Insert Domain Receptor/Inhibitor of DNA Binding-3 Autocrine Pathway
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4603 - 4611.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Chen, M. E. Rose, H. Hwang, R. G. Nines, and G. D. Stoner
Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS
Carcinogenesis, November 1, 2006; 27(11): 2301 - 2307.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N G. de la Torre, I Buley, J A H Wass, and H E Turner
Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 931 - 944.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P. Siironen, A. Ristimaki, K. Narko, S. Nordling, J. Louhimo, S. Andersson, R. Haapiainen, and C. Haglund
VEGF-C and COX-2 expression in papillary thyroid cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 465 - 473.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe
Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X.-M. Yu, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, P. Leung, and J. M. Luk
Increased Expression of Vascular Endothelial Growth Factor C in Papillary Thyroid Carcinoma Correlates with Cervical Lymph Node Metastases
Clin. Cancer Res., November 15, 2005; 11(22): 8063 - 8069.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. M. Vieira, S. C R. Santos, C. Espadinha, I. Correia, T. Vag, C. Casalou, B. M. Cavaco, A. L. Catarino, S. Dias, and V. Leite
Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop
Eur. J. Endocrinol., November 1, 2005; 153(5): 701 - 709.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Chen, M. L. Varney, M. W. Backora, K. Cowan, J. C. Solheim, J. E. Talmadge, and R. K. Singh
Down-Regulation of Vascular Endothelial Cell Growth Factor-C Expression Using Small Interfering RNA Vectors in Mammary Tumors Inhibits Tumor Lymphangiogenesis and Spontaneous Metastasis and Enhances Survival
Cancer Res., October 1, 2005; 65(19): 9004 - 9011.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Lacroix, V. Lazar, S. Michiels, H. Ripoche, P. Dessen, M. Talbot, B. Caillou, J.-P. Levillain, M. Schlumberger, and J.-M. Bidart
Follicular Thyroid Tumors with the PAX8-PPAR{gamma}1 Rearrangement Display Characteristic Genetic Alterations
Am. J. Pathol., July 1, 2005; 167(1): 223 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. N. Younes, O. G. Yigitbasi, Y. W. Park, S.-J. Kim, S. A. Jasser, V. S. Hawthorne, Y. D. Yazici, M. Mandal, B. N. Bekele, C. D. Bucana, et al.
Antivascular Therapy of Human Follicular Thyroid Cancer Experimental Bone Metastasis by Blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor Phosphorylation
Cancer Res., June 1, 2005; 65(11): 4716 - 4727.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ueda, Y.-C. Hung, Y. Terai, K. Kanda, M. Kanemura, H. Futakuchi, H. Yamaguchi, D. Akise, M. Yasuda, and M. Ueki
Vascular Endothelial Growth Factor-C Expression and Invasive Phenotype in Ovarian Carcinomas
Clin. Cancer Res., May 1, 2005; 11(9): 3225 - 3232.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
A M Jubb, T Q Pham, A M Hanby, G D Frantz, F V Peale, T D Wu, H W Koeppen, and K J Hillan
Expression of vascular endothelial growth factor, hypoxia inducible factor 1{alpha}, and carbonic anhydrase IX in human tumours
J. Clin. Pathol., May 1, 2004; 57(5): 504 - 512.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Schoenberger, D. Grimm, P. Kossmehl, M. Infanger, E. Kurth, and C. Eilles
Effects of PTK787/ZK222584, a Tyrosine Kinase Inhibitor, on the Growth of a Poorly Differentiated Thyroid Carcinoma: An Animal Study
Endocrinology, March 1, 2004; 145(3): 1031 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Ye, C. Feng, S. Wang, K. Z. Q. Wang, N. Huang, X. Liu, Y. Lin, and M. Li
sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma
Endocrinology, February 1, 2004; 145(2): 817 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. P. Padera, Y. Boucher, R. K. Jain, L. M. Wein, P. E. Holden, and D. H. Kirn
Correspondence re: S. Maula et al., Intratumoral Lymphatics Are Essential for the Metastatic Spread and Prognosis in Squamous Cell Carcinoma of the Head and Neck. Cancer Res., 63: 1920-1926, 2003.
Cancer Res., December 1, 2003; 63(23): 8555 - 8557.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Poulaki, C. S. Mitsiades, C. McMullan, D. Sykoutri, G. Fanourakis, V. Kotoula, S. Tseleni-Balafouta, D. A. Koutras, and N. Mitsiades
Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid Carcinomas
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5392 - 5398.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Sorvillo, G. Mazziotti, A. Carbone, M. Piscopo, M. Rotondi, M. Cioffi, P. Musto, B. Biondi, S. Iorio, G. Amato, et al.
Recombinant Human Thyrotropin Reduces Serum Vascular Endothelial Growth Factor Levels in Patients Monitored for Thyroid Carcinoma Even in the Absence of Thyroid Tissue
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4818 - 4822.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A.-C. Gerard, C. Daumerie, C. Mestdagh, S. Gohy, C. de Burbure, S. Costagliola, F. Miot, M.-C. Nollevaux, J.-F. Denef, J. Rahier, et al.
Correlation between the Loss of Thyroglobulin Iodination and the Expression of Thyroid-Specific Proteins Involved in Iodine Metabolism in Thyroid Carcinomas
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4977 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Hung, D. G. Ginzinger, R. Zarnegar, H. Kanauchi, M. G. Wong, E. Kebebew, O. H. Clark, and Q.-Y. Duh
Expression of Vascular Endothelial Growth Factor-C in Benign and Malignant Thyroid Tumors
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3694 - 3699.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
F. T. Hall, J. L. Freeman, S. L. Asa, D. G. Jackson, and N. J. Beasley
Intratumoral Lymphatics and Lymph Node Metastases in Papillary Thyroid Carcinoma
Arch Otolaryngol Head Neck Surg, July 1, 2003; 129(7): 716 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P.-W. Tsai, S.-G. Shiah, M.-T. Lin, C.-W. Wu, and M.-L. Kuo
Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-beta 1. A CRITICAL ROLE OF p38/NUCLEAR FACTOR-kappa B SIGNALING PATHWAY
J. Biol. Chem., February 14, 2003; 278(8): 5750 - 5759.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Ye, C. Feng, S. Wang, X. Liu, Y. Lin, and M. Li
Antiangiogenic and Antitumor Effects of Endostatin on Follicular Thyroid Carcinoma
Endocrinology, September 1, 2002; 143(9): 3522 - 3528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. F. Schoppmann, P. Birner, J. Stockl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo, and D. Kerjaschki
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
Am. J. Pathol., September 1, 2002; 161(3): 947 - 956.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. J. Bernardi, C. S. Johnson, R. A. Modzelewski, and D. L. Trump
Antiproliferative Effects of 1{alpha},25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells
Endocrinology, July 1, 2002; 143(7): 2508 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. A. STACKER, M. E. BALDWIN, and M. G. ACHEN
The role of tumor lymphangiogenesis in metastatic spread
FASEB J, July 1, 2002; 16(9): 922 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. K. Jain and T. P. Padera
Prevention and Treatment of Lymphatic Metastasis by Antilymphangiogenic Therapy
J Natl Cancer Inst, June 5, 2002; 94(11): 785 - 787.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Tanaka, H. Sonoo, J. Kurebayashi, T. Nomura, S. Ohkubo, Y. Yamamoto, and S. Yamamoto
Inhibition of Infiltration and Angiogenesis by Thrombospondin-1 in Papillary Thyroid Carcinoma
Clin. Cancer Res., May 1, 2002; 8(5): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. M. Tuttle, M. Fleisher, G. L. Francis, and R. J. Robbins
Serum Vascular Endothelial Growth Factor Levels Are Elevated in Metastatic Differentiated Thyroid Cancer but Not Increased by Short-Term TSH Stimulation
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1737 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Hawighorst, M. Skobe, M. Streit, Y.-K. Hong, P. Velasco, L. F. Brown, L. Riccardi, B. Lange-Asschenfeldt, and M. Detmar
Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth
Am. J. Pathol., April 1, 2002; 160(4): 1381 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. K. Jain and B. T. Fenton
Intratumoral Lymphatic Vessels: A Case of Mistaken Identity or Malfunction?
J Natl Cancer Inst, March 20, 2002; 94(6): 417 - 421.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression
Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-Q. Huang, J.-J. Li, L. Hu, M. Lee, and S. Karpatkin
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
Blood, March 1, 2002; 99(5): 1646 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Karpanen and K. Alitalo
Lymphatic Vessels as Targets of Tumor Therapy?
J. Exp. Med., September 17, 2001; 194(6): F37 - F42.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Kodama, I. Hashimoto, N. Seki, A. Hongo, M. Yoshinouchi, H. Okuda, and T. Kudo
Thrombospondin-1 and -2 Messenger RNA Expression in Invasive Cervical Cancer: Correlation with Angiogenesis and Prognosis
Clin. Cancer Res., September 1, 2001; 7(9): 2826 - 2831.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas
Am. J. Pathol., July 1, 2001; 159(1): 223 - 235.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. D. Ramsden, H. C. Cocks, M. Shams, S. Nijjar, J. C. Watkinson, M. C. Sheppard, A. Ahmed, and M. C. Eggo
Tie-2 Is Expressed on Thyroid Follicular Cells, Is Increased in Goiter, and Is Regulated by Thyrotropin through Cyclic Adenosine 3',5'-Monophosphate
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2709 - 2716.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. S. Pepper
Lymphangiogenesis and Tumor Metastasis: Myth or Reality?
Clin. Cancer Res., March 1, 2001; 7(3): 462 - 468.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox
The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers
Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. J. Mandriota, C. Pyke, C. Di Sanza, P. Quinodoz, B. Pittet, and M. S. Pepper
Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue Ischemia
Am. J. Pathol., June 1, 2000; 156(6): 2077 - 2089.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.